219 related articles for article (PubMed ID: 12851770)
1. [Overactive bladder--treatment with antimuscarinic agents].
Höfner K
Urologe A; 2003 Jun; 42(6):793-800. PubMed ID: 12851770
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptor antagonists for overactive bladder.
Abrams P; Andersson KE
BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
[TBL] [Abstract][Full Text] [Related]
3. [Changes in muscarinic receptors of the aging bladder].
Andersson KE; Schröder A
Urologe A; 2004 May; 43(5):552-6. PubMed ID: 15098089
[TBL] [Abstract][Full Text] [Related]
4. [New pharmacological treatment concepts for overactive bladder].
Michel MC
Urologe A; 2003 Jun; 42(6):807-11. PubMed ID: 12851772
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptors in the bladder: from basic research to therapeutics.
Hegde SS
Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186
[TBL] [Abstract][Full Text] [Related]
6. Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence.
Badawi JK; Langbein S
Pharmazie; 2006 Mar; 61(3):175-8. PubMed ID: 16599254
[TBL] [Abstract][Full Text] [Related]
7. Antimuscarinics for treatment of overactive bladder.
Andersson KE
Lancet Neurol; 2004 Jan; 3(1):46-53. PubMed ID: 14693111
[TBL] [Abstract][Full Text] [Related]
8. [Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison].
Goepel M; Schultz-Lampel D
Urologe A; 2011 Jul; 50(7):802-5. PubMed ID: 21681456
[TBL] [Abstract][Full Text] [Related]
9. Local effects of antimuscarinics.
Masuda H; Kim YT; Tyagi S; Chancellor MB; de Miguel F; Yoshimura N
Urol Clin North Am; 2006 Nov; 33(4):511-8, ix-x. PubMed ID: 17011387
[TBL] [Abstract][Full Text] [Related]
10. Which muscarinic receptor is important in the bladder?
Yamanishi T; Chapple CR; Chess-Williams R
World J Urol; 2001 Nov; 19(5):299-306. PubMed ID: 11760777
[TBL] [Abstract][Full Text] [Related]
11. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Garely AD; Lucente V; Vapnek J; Smith N
Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.
Abrams P; Andersson KE; Buccafusco JJ; Chapple C; de Groat WC; Fryer AD; Kay G; Laties A; Nathanson NM; Pasricha PJ; Wein AJ
Br J Pharmacol; 2006 Jul; 148(5):565-78. PubMed ID: 16751797
[TBL] [Abstract][Full Text] [Related]
13. Role of muscarinic receptor antagonists in urgency and nocturia.
Michel MC; de la Rosette JJ
BJU Int; 2005 Sep; 96 Suppl 1():37-42. PubMed ID: 16083453
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
Wagg A; Wyndaele JJ; Sieber P
Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
[TBL] [Abstract][Full Text] [Related]
15. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies.
Hegde SS; Mammen M; Jasper JR
Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972
[TBL] [Abstract][Full Text] [Related]
16. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly.
Kay GG; Granville LJ
Clin Ther; 2005 Jan; 27(1):127-38; quiz 139-40. PubMed ID: 15763613
[TBL] [Abstract][Full Text] [Related]
17. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
Kay GG; Abou-Donia MB; Messer WS; Murphy DG; Tsao JW; Ouslander JG
J Am Geriatr Soc; 2005 Dec; 53(12):2195-201. PubMed ID: 16398909
[TBL] [Abstract][Full Text] [Related]
18. Darifenacin in the treatment of overactive bladder.
Haab F
Drugs Today (Barc); 2005 Jul; 41(7):441-52. PubMed ID: 16193097
[TBL] [Abstract][Full Text] [Related]
19. Tolterodine use for symptoms of overactive bladder.
Ruscin JM; Morgenstern NE
Ann Pharmacother; 1999 Oct; 33(10):1073-82. PubMed ID: 10534221
[TBL] [Abstract][Full Text] [Related]
20. Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence?
Gibson W; Athanasopoulos A; Goldman H; Madersbacher H; Newman D; Spinks J; Wyndaele JJ; Wagg A
Int J Clin Pract; 2014 Sep; 68(9):1165-73. PubMed ID: 25196247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
